Hum. Reprod. Advance Access published online on January 29, 2004
Human Reproduction, doi:10.1093/humrep/deh096
© 2004 by European Society of Human Reproduction and Embryology
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Williamson Laboratory, St Bartholomew’s and The London Hospitals Trust, London EC1A, UK; Centre for Reproductive Medicine, St Bartholomew’s and Royal London Hospital, Queen Mary School of Medicine and Dentistry, London E1 1BB, UK
* To whom correspondence should be addressed. E-mail: ggrudzinskas{at}thebridgecentre.co.uk.
BACKGROUND: The aim of this study was to assess the effect of withholding gonadotrophins (coasting) during controlled ovarian stimulation (COS) on individual follicle concentrations of follicular fluid vascular endothelial growth factor (VEGF) in women at high risk of developing ovarian hyperstimulation syndrome (OHSS). METHODS: Twenty-two women who had been coasted and 26 optimally responding women (control group) undergoing COS for IVF were studied. At the time of oocyte retrieval, the follicular fluid from four to six individual follicles of different sizes was collected for VEGF analysis. RESULTS: A total of 118 follicles was analysed in the coasted group and 137 in the control group. A negative correlation was observed between the follicle size and VEGF concentration (r = -0.18, P = 0.03) in the control group, which was not seen in the coasted group. Similarly, the correlation between oestradiol (E2) and VEGF (r = 0.4, P < 0.0001) observed in the control group was not apparent in the coasted group. Significantly lower concentrations of VEGF were seen in the follicular fluid of the coasted patients. CONCLUSIONS: It is clear that there are differences in follicular fluid VEGF concentrations between the two groups. It is possible that coasting alters the capacity of the granulosa cells to produce VEGF and/or their response to hCG and in this way acts to reduce the severity and incidence of severe OHSS. Key words:
Key words: coasting/controlled ovarian stimulation/ovarian hyperstimulation syndrome/vascular endothelial growth factor
Accepted October 30, 2003
Article
The effects of coasting on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome
2 Williamson Laboratory, St Bartholomew’s and The London Hospitals Trust, London EC1A, UK; Department of Biological and Applied Science, University of North London, Holloway Road, London, UK
3 Williamson Laboratory, St Bartholomew’s and The London Hospitals Trust, London EC1A, UK
4 Centre for Reproductive Medicine, St Bartholomew’s and Royal London Hospital, Queen Mary School of Medicine and Dentistry, London E1 1BB, UK
5 Centre for Reproductive Medicine, St Bartholomew’s and Royal London Hospital, Queen Mary School of Medicine and Dentistry, London E1 1BB, UK; The Bridge Centre, London Bridge, London SE19RY, UK
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. A. Aboulghar Preventing Ovarian Hyperstimulation Syndrome J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2882 - 2884. [Full Text] [PDF] |
||||
![]() |
D. Manau, F. Fabregues, J. Penarrubia, M. Creus, F. Carmona, G. Casals, W. Jimenez, and J. Balasch Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF Hum. Reprod., March 1, 2007; 22(3): 669 - 675. [Abstract] [Full Text] [PDF] |
||||

